CAMP and lung cancer: Activation of myeloid cells such as macrophages to release the inflammatory cytokine cathelicidin (HCAP18/LL-37, Human cationic antimicrobial protein 18) and induce proliferation of lung cancer cells has also been demonstrated [14].